Open AccessPostoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study
Author(s) -
Zhenggang Ren,
Zhiying Lin,
Jinglin Xia,
ShengLong Ye,
ZengChen Ma,
Qing–Hai Ye,
LunXiu Qin,
ZhiQuan Wu,
Jia Fan,
Zhao–You Tang
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i19.2791
Subject(s) - medicine , hepatocellular carcinoma , transcatheter arterial chemoembolization , hazard ratio , proportional hazards model , adjuvant , retrospective cohort study , adjuvant therapy , gastroenterology , surgery , cirrhosis , survival analysis , confidence interval , cancer
To evaluate the effect of postoperative adjuvant transcatheter arterial chemoembolization (TACE) on the prognosis of hepatocellular carcinoma (HCC) patients with or without risk factors for the residual tumor.